CCK receptor

Isoform-selective Products

CCK receptor Products

  • All (5)
  • CCK receptor Inhibitor (1)
  • CCK receptor Activator (1)
  • CCK receptor Antagonist (1)
  • CCK receptor Agonist (1)
  • CCK receptor Modulator (1)
  • New CCK receptor Products
Catalog No. Product Name Information Product Use Citations Product Validations
S2032 Rebamipide Rebamipide (OPC-12759,Proamipide) is a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [125I]BH-CCK-8S with IC50 of 37.7 μM.
Signal Transduct Target Ther, 2021, 6(1):148
University of Alberta, 2014, Yahya Muhammad Fiteih
P1249New Gastrin I, human Gastrin I, human is an important analogue of gastrin, an endogenous gastrointestinal peptide hormone. It plays key roles in digestion and energy homeostasis via CCK2 receptor activation in digestive processes including gastric acid secretion, pancreatic enzyme release, gallbladder emptying, gut motility.
S9690 Caerulein (FI-6934) Caerulein (Ceruletide, Cerulein, FI-6934), a cholecystokinin (CCK) receptor agonist, is a safe and effective cholecystokinetic agent and small bowel and exocrine pancreatic stimulant. Caerulein (FI-6934) can be used to induce animal models of acute pancreatitis.
J Adv Res, 2025, S2090-1232(25)00225-5
E7316New Cholecystokinin Octapeptide, desulfated Cholecystokinin Octapeptide, desulfated, (CCK-8 (desulphated)) is a synthetic peptide lacking the sulfate group on its tyrosine residue, reducing its activity at CCK-A receptors while allowing selective binding to CCK-B receptors. It is used in research to study central and gastric effects mediated by CCK-B receptors, independent of digestive enzyme stimulation.
S6939 Nastorazepide Nastorazepide (Z-360), a cholecystokinin-2/gastrin receptor (CCK2/gastrin receptor) antagonist, combines with gemcitabine prolonged survival and reduces gemcitabine-induced vascular endothelial growth factor (VEGF) expression in a pancreatic carcinoma orthotopic xenograft mouse.
S2032 Rebamipide Rebamipide (OPC-12759,Proamipide) is a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [125I]BH-CCK-8S with IC50 of 37.7 μM.
Signal Transduct Target Ther, 2021, 6(1):148
University of Alberta, 2014, Yahya Muhammad Fiteih
P1249New Gastrin I, human Gastrin I, human is an important analogue of gastrin, an endogenous gastrointestinal peptide hormone. It plays key roles in digestion and energy homeostasis via CCK2 receptor activation in digestive processes including gastric acid secretion, pancreatic enzyme release, gallbladder emptying, gut motility.
S6939 Nastorazepide Nastorazepide (Z-360), a cholecystokinin-2/gastrin receptor (CCK2/gastrin receptor) antagonist, combines with gemcitabine prolonged survival and reduces gemcitabine-induced vascular endothelial growth factor (VEGF) expression in a pancreatic carcinoma orthotopic xenograft mouse.
S9690 Caerulein (FI-6934) Caerulein (Ceruletide, Cerulein, FI-6934), a cholecystokinin (CCK) receptor agonist, is a safe and effective cholecystokinetic agent and small bowel and exocrine pancreatic stimulant. Caerulein (FI-6934) can be used to induce animal models of acute pancreatitis.
J Adv Res, 2025, S2090-1232(25)00225-5
E7316New Cholecystokinin Octapeptide, desulfated Cholecystokinin Octapeptide, desulfated, (CCK-8 (desulphated)) is a synthetic peptide lacking the sulfate group on its tyrosine residue, reducing its activity at CCK-A receptors while allowing selective binding to CCK-B receptors. It is used in research to study central and gastric effects mediated by CCK-B receptors, independent of digestive enzyme stimulation.
P1249New Gastrin I, human Gastrin I, human is an important analogue of gastrin, an endogenous gastrointestinal peptide hormone. It plays key roles in digestion and energy homeostasis via CCK2 receptor activation in digestive processes including gastric acid secretion, pancreatic enzyme release, gallbladder emptying, gut motility.
E7316New Cholecystokinin Octapeptide, desulfated Cholecystokinin Octapeptide, desulfated, (CCK-8 (desulphated)) is a synthetic peptide lacking the sulfate group on its tyrosine residue, reducing its activity at CCK-A receptors while allowing selective binding to CCK-B receptors. It is used in research to study central and gastric effects mediated by CCK-B receptors, independent of digestive enzyme stimulation.

Choose Selective CCK receptor Inhibitors

Tags: CCK receptor inhibitor|CCK receptor agonist|CCK receptor activator|CCK receptor inducer|CCK receptor antagonist|CCK receptor signaling pathway|CCK receptor assay kit